| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | translation activator activity | 1.31e-12 | 15 | 19 | 5 | GO:0008494 | |
| GeneOntologyMolecularFunction | translation regulator activity, nucleic acid binding | 5.54e-08 | 112 | 19 | 5 | GO:0090079 | |
| GeneOntologyMolecularFunction | mRNA 3'-UTR binding | 1.54e-07 | 276 | 19 | 6 | GO:0003730 | |
| GeneOntologyMolecularFunction | histone H3K14 acetyltransferase activity | 3.08e-05 | 9 | 19 | 2 | GO:0036408 | |
| GeneOntologyMolecularFunction | mRNA binding | 3.18e-05 | 694 | 19 | 6 | GO:0003729 | |
| GeneOntologyMolecularFunction | translation regulator activity | 4.72e-05 | 443 | 19 | 5 | GO:0045182 | |
| GeneOntologyMolecularFunction | histone H3 acetyltransferase activity | 8.94e-05 | 15 | 19 | 2 | GO:0010484 | |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 1.06e-03 | 51 | 19 | 2 | GO:0004402 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 1.24e-03 | 55 | 19 | 2 | GO:0061733 | |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 1.47e-03 | 60 | 19 | 2 | GO:0034212 | |
| GeneOntologyMolecularFunction | N-acetyltransferase activity | 2.47e-03 | 78 | 19 | 2 | GO:0008080 | |
| GeneOntologyMolecularFunction | N-acyltransferase activity | 4.17e-03 | 102 | 19 | 2 | GO:0016410 | |
| GeneOntologyMolecularFunction | acetyltransferase activity | 4.34e-03 | 104 | 19 | 2 | GO:0016407 | |
| GeneOntologyBiologicalProcess | female meiosis II | 7.70e-12 | 6 | 19 | 4 | GO:0007147 | |
| GeneOntologyBiologicalProcess | meiosis II | 7.70e-12 | 6 | 19 | 4 | GO:0007135 | |
| GeneOntologyBiologicalProcess | meiosis II cell cycle process | 7.70e-12 | 6 | 19 | 4 | GO:0061983 | |
| GeneOntologyBiologicalProcess | positive regulation of translational initiation | 4.38e-11 | 29 | 19 | 5 | GO:0045948 | |
| GeneOntologyBiologicalProcess | 3'-UTR-mediated mRNA stabilization | 6.26e-11 | 31 | 19 | 5 | GO:0070935 | |
| GeneOntologyBiologicalProcess | positive regulation of translation | 3.49e-09 | 151 | 19 | 6 | GO:0045727 | |
| GeneOntologyBiologicalProcess | mRNA stabilization | 7.09e-09 | 77 | 19 | 5 | GO:0048255 | |
| GeneOntologyBiologicalProcess | positive regulation of meiotic nuclear division | 7.59e-09 | 26 | 19 | 4 | GO:0045836 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA catabolic process | 1.32e-08 | 87 | 19 | 5 | GO:1902373 | |
| GeneOntologyBiologicalProcess | RNA stabilization | 1.40e-08 | 88 | 19 | 5 | GO:0043489 | |
| GeneOntologyBiologicalProcess | regulation of translational initiation | 1.66e-08 | 91 | 19 | 5 | GO:0006446 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA catabolic process | 2.81e-08 | 101 | 19 | 5 | GO:1902369 | |
| GeneOntologyBiologicalProcess | positive regulation of meiotic cell cycle | 3.33e-08 | 37 | 19 | 4 | GO:0051446 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA metabolic process | 5.39e-08 | 115 | 19 | 5 | GO:1903312 | |
| GeneOntologyBiologicalProcess | regulation of meiotic nuclear division | 7.48e-08 | 45 | 19 | 4 | GO:0040020 | |
| GeneOntologyBiologicalProcess | oocyte maturation | 8.94e-08 | 47 | 19 | 4 | GO:0001556 | |
| GeneOntologyBiologicalProcess | translational initiation | 1.08e-07 | 132 | 19 | 5 | GO:0006413 | |
| GeneOntologyBiologicalProcess | female meiotic nuclear division | 1.35e-07 | 52 | 19 | 4 | GO:0007143 | |
| GeneOntologyBiologicalProcess | meiotic cell cycle | 5.15e-07 | 350 | 19 | 6 | GO:0051321 | |
| GeneOntologyBiologicalProcess | positive regulation of nuclear division | 6.00e-07 | 75 | 19 | 4 | GO:0051785 | |
| GeneOntologyBiologicalProcess | regulation of meiotic cell cycle | 8.59e-07 | 82 | 19 | 4 | GO:0051445 | |
| GeneOntologyBiologicalProcess | oocyte development | 1.83e-06 | 99 | 19 | 4 | GO:0048599 | |
| GeneOntologyBiologicalProcess | oocyte differentiation | 2.15e-06 | 103 | 19 | 4 | GO:0009994 | |
| GeneOntologyBiologicalProcess | positive regulation of reproductive process | 3.69e-06 | 118 | 19 | 4 | GO:2000243 | |
| GeneOntologyBiologicalProcess | regulation of translation | 3.81e-06 | 494 | 19 | 6 | GO:0006417 | |
| GeneOntologyBiologicalProcess | regulation of mRNA stability | 5.43e-06 | 292 | 19 | 5 | GO:0043488 | |
| GeneOntologyBiologicalProcess | regulation of RNA stability | 7.04e-06 | 308 | 19 | 5 | GO:0043487 | |
| GeneOntologyBiologicalProcess | regulation of mRNA catabolic process | 7.15e-06 | 309 | 19 | 5 | GO:0061013 | |
| GeneOntologyBiologicalProcess | oogenesis | 1.12e-05 | 156 | 19 | 4 | GO:0048477 | |
| GeneOntologyBiologicalProcess | regulation of nuclear division | 1.64e-05 | 172 | 19 | 4 | GO:0051783 | |
| GeneOntologyBiologicalProcess | mRNA catabolic process | 1.78e-05 | 373 | 19 | 5 | GO:0006402 | |
| GeneOntologyBiologicalProcess | positive regulation of gene expression | 2.15e-05 | 1446 | 19 | 8 | GO:0010628 | |
| GeneOntologyBiologicalProcess | positive regulation of protein metabolic process | 2.28e-05 | 1458 | 19 | 8 | GO:0051247 | |
| GeneOntologyBiologicalProcess | negative regulation of catabolic process | 3.07e-05 | 418 | 19 | 5 | GO:0009895 | |
| GeneOntologyBiologicalProcess | RNA catabolic process | 3.59e-05 | 432 | 19 | 5 | GO:0006401 | |
| GeneOntologyBiologicalProcess | regulation of mRNA metabolic process | 4.05e-05 | 443 | 19 | 5 | GO:1903311 | |
| GeneOntologyBiologicalProcess | female gamete generation | 4.54e-05 | 223 | 19 | 4 | GO:0007292 | |
| GeneOntologyBiologicalProcess | nucleic acid catabolic process | 5.05e-05 | 464 | 19 | 5 | GO:0141188 | |
| GeneOntologyBiologicalProcess | meiotic nuclear division | 6.04e-05 | 240 | 19 | 4 | GO:0140013 | |
| GeneOntologyBiologicalProcess | transition between fast and slow fiber | 6.23e-05 | 13 | 19 | 2 | GO:0014883 | |
| GeneOntologyBiologicalProcess | translation | 6.93e-05 | 824 | 19 | 6 | GO:0006412 | |
| GeneOntologyBiologicalProcess | regulation of reproductive process | 7.19e-05 | 251 | 19 | 4 | GO:2000241 | |
| GeneOntologyBiologicalProcess | cell maturation | 9.13e-05 | 267 | 19 | 4 | GO:0048469 | |
| GeneOntologyBiologicalProcess | meiotic cell cycle process | 9.26e-05 | 268 | 19 | 4 | GO:1903046 | |
| GeneOntologyBiologicalProcess | regulation of skeletal muscle adaptation | 1.51e-04 | 20 | 19 | 2 | GO:0014733 | |
| GeneOntologyBiologicalProcess | positive regulation of cell cycle process | 1.56e-04 | 307 | 19 | 4 | GO:0090068 | |
| GeneOntologyBiologicalProcess | anatomical structure maturation | 2.70e-04 | 354 | 19 | 4 | GO:0071695 | |
| GeneOntologyBiologicalProcess | nucleobase-containing compound catabolic process | 3.38e-04 | 696 | 19 | 5 | GO:0034655 | |
| GeneOntologyBiologicalProcess | skeletal muscle adaptation | 3.92e-04 | 32 | 19 | 2 | GO:0043501 | |
| GeneOntologyBiologicalProcess | post-transcriptional regulation of gene expression | 4.35e-04 | 1153 | 19 | 6 | GO:0010608 | |
| GeneOntologyBiologicalProcess | positive regulation of cell cycle | 4.58e-04 | 407 | 19 | 4 | GO:0045787 | |
| GeneOntologyBiologicalProcess | spermatogenesis | 4.60e-04 | 744 | 19 | 5 | GO:0007283 | |
| GeneOntologyBiologicalProcess | male gamete generation | 5.13e-04 | 762 | 19 | 5 | GO:0048232 | |
| GeneOntologyBiologicalProcess | developmental maturation | 6.09e-04 | 439 | 19 | 4 | GO:0021700 | |
| GeneOntologyBiologicalProcess | germ cell development | 8.64e-04 | 482 | 19 | 4 | GO:0007281 | |
| GeneOntologyBiologicalProcess | sexual reproduction | 8.65e-04 | 1312 | 19 | 6 | GO:0019953 | |
| GeneOntologyBiologicalProcess | nuclear division | 1.08e-03 | 512 | 19 | 4 | GO:0000280 | |
| GeneOntologyBiologicalProcess | mRNA metabolic process | 1.19e-03 | 917 | 19 | 5 | GO:0016071 | |
| GeneOntologyBiologicalProcess | cellular process involved in reproduction in multicellular organism | 1.20e-03 | 527 | 19 | 4 | GO:0022412 | |
| GeneOntologyBiologicalProcess | gamete generation | 1.61e-03 | 982 | 19 | 5 | GO:0007276 | |
| GeneOntologyBiologicalProcess | organelle fission | 1.62e-03 | 571 | 19 | 4 | GO:0048285 | |
| GeneOntologyBiologicalProcess | positive regulation of organelle organization | 1.65e-03 | 574 | 19 | 4 | GO:0010638 | |
| GeneOntologyBiologicalProcess | striated muscle adaptation | 2.03e-03 | 73 | 19 | 2 | GO:0014888 | |
| GeneOntologyBiologicalProcess | multicellular organismal reproductive process | 3.79e-03 | 1194 | 19 | 5 | GO:0048609 | |
| GeneOntologyBiologicalProcess | developmental process involved in reproduction | 4.38e-03 | 1235 | 19 | 5 | GO:0003006 | |
| GeneOntologyBiologicalProcess | regulation of catabolic process | 4.65e-03 | 1252 | 19 | 5 | GO:0009894 | |
| GeneOntologyBiologicalProcess | nucleosome assembly | 5.56e-03 | 122 | 19 | 2 | GO:0006334 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | 6.24e-03 | 1342 | 19 | 5 | GO:0033043 | |
| GeneOntologyBiologicalProcess | regulation of muscle adaptation | 6.57e-03 | 133 | 19 | 2 | GO:0043502 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle process | 6.63e-03 | 845 | 19 | 4 | GO:0010564 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | 6.72e-03 | 1366 | 19 | 5 | GO:0051130 | |
| GeneOntologyBiologicalProcess | nucleosome organization | 7.45e-03 | 142 | 19 | 2 | GO:0034728 | |
| GeneOntologyCellularComponent | ribosome | 3.29e-06 | 267 | 19 | 5 | GO:0005840 | |
| GeneOntologyCellularComponent | MOZ/MORF histone acetyltransferase complex | 1.64e-05 | 7 | 19 | 2 | GO:0070776 | |
| GeneOntologyCellularComponent | H3 histone acetyltransferase complex | 2.18e-05 | 8 | 19 | 2 | GO:0070775 | |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 3.25e-03 | 94 | 19 | 2 | GO:0000123 | |
| GeneOntologyCellularComponent | protein acetyltransferase complex | 3.97e-03 | 104 | 19 | 2 | GO:0031248 | |
| GeneOntologyCellularComponent | acetyltransferase complex | 4.35e-03 | 109 | 19 | 2 | GO:1902493 | |
| HumanPheno | Oligozoospermia | 3.24e-06 | 59 | 10 | 4 | HP:0000798 | |
| HumanPheno | Y-linked inheritance | 4.38e-06 | 18 | 10 | 3 | HP:0001450 | |
| HumanPheno | Abnormal internal genitalia | 4.73e-06 | 1498 | 10 | 10 | HP:0000812 | |
| HumanPheno | Cryptorchidism | 1.51e-04 | 780 | 10 | 7 | HP:0000028 | |
| HumanPheno | Hypoplastic male external genitalia | 1.51e-04 | 514 | 10 | 6 | HP:0000050 | |
| HumanPheno | Abnormal testis morphology | 1.66e-04 | 1129 | 10 | 8 | HP:0000035 | |
| HumanPheno | Non-obstructive azoospermia | 1.70e-04 | 1132 | 10 | 8 | HP:0011961 | |
| HumanPheno | Neoplasm of the oral cavity | 1.94e-04 | 62 | 10 | 3 | HP:0100649 | |
| HumanPheno | Azoospermia | 2.00e-04 | 1157 | 10 | 8 | HP:0000027 | |
| HumanPheno | External genital hypoplasia | 2.08e-04 | 544 | 10 | 6 | HP:0003241 | |
| HumanPheno | Abnormal spermatogenesis | 2.47e-04 | 1190 | 10 | 8 | HP:0008669 | |
| HumanPheno | Abnormal male internal genitalia morphology | 3.42e-04 | 1243 | 10 | 8 | HP:0000022 | |
| HumanPheno | Functional abnormality of male internal genitalia | 3.99e-04 | 1269 | 10 | 8 | HP:0000025 | |
| HumanPheno | Decreased testicular size | 4.02e-04 | 200 | 10 | 4 | HP:0008734 | |
| HumanPheno | Male infertility | 4.76e-04 | 209 | 10 | 4 | HP:0003251 | |
| HumanPheno | Abnormal male reproductive system physiology | 5.18e-04 | 1314 | 10 | 8 | HP:0012874 | |
| HumanPheno | Abnormal male external genitalia morphology | 5.63e-04 | 1329 | 10 | 8 | HP:0000032 | |
| HumanPheno | Aplasia/Hypoplasia of the testes | 5.89e-04 | 221 | 10 | 4 | HP:0010468 | |
| HumanPheno | Abnormal external genitalia | 7.13e-04 | 1372 | 10 | 8 | HP:0000811 | |
| HumanPheno | Decreased fertility in males | 7.56e-04 | 236 | 10 | 4 | HP:0012041 | |
| HumanPheno | Abnormality of the testis size | 7.81e-04 | 238 | 10 | 4 | HP:0045058 | |
| MousePheno | absent ovarian follicles | 1.10e-07 | 51 | 13 | 4 | MP:0002777 | |
| MousePheno | abnormal sperm number | 4.63e-07 | 624 | 13 | 7 | MP:0002673 | |
| MousePheno | arrest of spermatogenesis | 1.61e-06 | 239 | 13 | 5 | MP:0001155 | |
| MousePheno | decreased male germ cell number | 1.17e-05 | 640 | 13 | 6 | MP:0004901 | |
| MousePheno | abnormal seminiferous tubule morphology | 1.50e-05 | 377 | 13 | 5 | MP:0002216 | |
| MousePheno | oligozoospermia | 1.64e-05 | 384 | 13 | 5 | MP:0002687 | |
| MousePheno | small ovary | 1.66e-05 | 178 | 13 | 4 | MP:0001127 | |
| MousePheno | abnormal gametogenesis | 1.72e-05 | 1070 | 13 | 7 | MP:0001929 | |
| MousePheno | decreased germ cell number | 1.76e-05 | 687 | 13 | 6 | MP:0002209 | |
| MousePheno | abnormal ovarian follicle number | 2.79e-05 | 203 | 13 | 4 | MP:0008871 | |
| MousePheno | abnormal gametes | 3.76e-05 | 785 | 13 | 6 | MP:0001124 | |
| MousePheno | abnormal ovary size | 4.39e-05 | 228 | 13 | 4 | MP:0004853 | |
| MousePheno | small testis | 4.91e-05 | 823 | 13 | 6 | MP:0001147 | |
| MousePheno | abnormal ovarian follicle morphology | 5.81e-05 | 245 | 13 | 4 | MP:0001131 | |
| MousePheno | abnormal male germ cell morphology | 6.25e-05 | 859 | 13 | 6 | MP:0006362 | |
| MousePheno | abnormal male reproductive system physiology | 7.08e-05 | 1329 | 13 | 7 | MP:0003698 | |
| MousePheno | small gonad | 7.39e-05 | 885 | 13 | 6 | MP:0001116 | |
| MousePheno | abnormal primary sex determination | 8.17e-05 | 901 | 13 | 6 | MP:0002211 | |
| MousePheno | abnormal spermatogenesis | 8.64e-05 | 910 | 13 | 6 | MP:0001156 | |
| MousePheno | abnormal testis size | 8.91e-05 | 915 | 13 | 6 | MP:0004849 | |
| MousePheno | male infertility | 1.06e-04 | 944 | 13 | 6 | MP:0001925 | |
| MousePheno | abnormal sex determination | 1.07e-04 | 945 | 13 | 6 | MP:0002210 | |
| MousePheno | abnormal germ cell morphology | 1.07e-04 | 946 | 13 | 6 | MP:0002208 | |
| MousePheno | abnormal foam cell morphology | 1.12e-04 | 954 | 13 | 6 | MP:0009840 | |
| MousePheno | abnormal testis morphology | 2.25e-04 | 1081 | 13 | 6 | MP:0001146 | |
| MousePheno | infertility | 3.78e-04 | 1188 | 13 | 6 | MP:0001924 | |
| MousePheno | female infertility | 4.22e-04 | 410 | 13 | 4 | MP:0001926 | |
| MousePheno | abnormal male reproductive gland morphology | 5.92e-04 | 1290 | 13 | 6 | MP:0013325 | |
| MousePheno | abnormal ovary morphology | 6.06e-04 | 451 | 13 | 4 | MP:0001126 | |
| MousePheno | abnormal female reproductive gland morphology | 7.37e-04 | 475 | 13 | 4 | MP:0013324 | |
| MousePheno | abnormal internal male genitalia morphology | 8.93e-04 | 1392 | 13 | 6 | MP:0009205 | |
| MousePheno | abnormal male reproductive system morphology | 9.75e-04 | 1415 | 13 | 6 | MP:0001145 | |
| MousePheno | abnormal male genitalia morphology | 9.75e-04 | 1415 | 13 | 6 | MP:0009198 | |
| MousePheno | skin edema | 1.07e-03 | 53 | 13 | 2 | MP:0001786 | |
| Domain | RRM | 5.49e-08 | 217 | 19 | 6 | SM00360 | |
| Domain | RRM_dom | 7.17e-08 | 227 | 19 | 6 | IPR000504 | |
| Domain | RRM | 7.75e-08 | 230 | 19 | 6 | PS50102 | |
| Domain | - | 1.10e-07 | 244 | 19 | 6 | 3.30.70.330 | |
| Domain | Nucleotide-bd_a/b_plait | 1.53e-07 | 258 | 19 | 6 | IPR012677 | |
| Domain | RRM_1 | 1.67e-06 | 208 | 19 | 5 | PF00076 | |
| Domain | GTF2I | 5.88e-06 | 4 | 19 | 2 | IPR004212 | |
| Domain | - | 5.88e-06 | 4 | 19 | 2 | 3.90.1460.10 | |
| Domain | GTF2I | 5.88e-06 | 4 | 19 | 2 | PS51139 | |
| Domain | GTF2I | 5.88e-06 | 4 | 19 | 2 | PF02946 | |
| Domain | MOZ_SAS | 9.79e-06 | 5 | 19 | 2 | PF01853 | |
| Domain | HAT_MYST-type | 9.79e-06 | 5 | 19 | 2 | IPR002717 | |
| Domain | MYST_HAT | 9.79e-06 | 5 | 19 | 2 | PS51726 | |
| Domain | H15 | 7.60e-05 | 13 | 19 | 2 | PS51504 | |
| Domain | H15 | 7.60e-05 | 13 | 19 | 2 | SM00526 | |
| Domain | Histone_H1/H5_H15 | 8.86e-05 | 14 | 19 | 2 | IPR005818 | |
| Domain | - | 7.47e-04 | 40 | 19 | 2 | 3.40.630.30 | |
| Domain | Acyl_CoA_acyltransferase | 9.46e-04 | 45 | 19 | 2 | IPR016181 | |
| Domain | - | 1.32e-03 | 218 | 19 | 3 | 1.10.10.10 | |
| Domain | WHTH_DNA-bd_dom | 1.79e-03 | 242 | 19 | 3 | IPR011991 | |
| Domain | RNaseH-like_dom | 2.21e-03 | 69 | 19 | 2 | IPR012337 | |
| Domain | PHD | 2.60e-03 | 75 | 19 | 2 | PF00628 | |
| Domain | Znf_PHD-finger | 2.88e-03 | 79 | 19 | 2 | IPR019787 | |
| Domain | PHD | 3.64e-03 | 89 | 19 | 2 | SM00249 | |
| Domain | Znf_PHD | 3.80e-03 | 91 | 19 | 2 | IPR001965 | |
| Domain | ZF_PHD_2 | 4.14e-03 | 95 | 19 | 2 | PS50016 | |
| Domain | ZF_PHD_1 | 4.22e-03 | 96 | 19 | 2 | PS01359 | |
| Domain | Znf_FYVE_PHD | 9.64e-03 | 147 | 19 | 2 | IPR011011 | |
| Pathway | WP_MALE_INFERTILITY | 3.00e-09 | 145 | 14 | 6 | M39856 | |
| Pathway | WP_OVARIAN_INFERTILITY | 3.13e-08 | 35 | 14 | 4 | MM15948 | |
| Pathway | WP_MRNA_PROCESSING | 5.17e-05 | 451 | 14 | 5 | MM15946 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | 1.72e-04 | 301 | 14 | 4 | MM15983 | |
| Pathway | REACTOME_HATS_ACETYLATE_HISTONES | 9.25e-04 | 46 | 14 | 2 | MM14935 | |
| Pubmed | Expression profiles of the DAZ gene family in human testis with and without spermatogenic failure. | 1.65e-16 | 6 | 19 | 5 | 15066460 | |
| Pubmed | 1.65e-16 | 6 | 19 | 5 | 11390979 | ||
| Pubmed | 1.65e-16 | 6 | 19 | 5 | 24086306 | ||
| Pubmed | 1.65e-16 | 6 | 19 | 5 | 27632217 | ||
| Pubmed | DAZL is a master translational regulator of murine spermatogenesis. | 1.65e-16 | 6 | 19 | 5 | 31355046 | |
| Pubmed | The DAZL family proteins are PABP-binding proteins that regulate translation in germ cells. | 1.65e-16 | 6 | 19 | 5 | 16001084 | |
| Pubmed | 3.52e-14 | 13 | 19 | 5 | 12511597 | ||
| Pubmed | Analysis of the DAZ gene family in cryptorchidism and idiopathic male infertility. | 6.36e-14 | 4 | 19 | 4 | 15066457 | |
| Pubmed | Male infertility caused by a de novo partial deletion of the DAZ cluster on the Y chromosome. | 6.36e-14 | 4 | 19 | 4 | 11095434 | |
| Pubmed | [Microdeletion of chromosome Y in male infertility: role of the DAZ gene]. | 6.36e-14 | 4 | 19 | 4 | 11688365 | |
| Pubmed | 6.36e-14 | 4 | 19 | 4 | 12752250 | ||
| Pubmed | A novel approach for the analysis of DAZ gene copy number in severely idiopathic infertile men. | 6.36e-14 | 4 | 19 | 4 | 11883873 | |
| Pubmed | 6.36e-14 | 4 | 19 | 4 | 7670487 | ||
| Pubmed | Impact of partial DAZ1/2 deletion and partial DAZ3/4 deletion on male infertility. | 6.36e-14 | 4 | 19 | 4 | 26232607 | |
| Pubmed | 6.36e-14 | 4 | 19 | 4 | 11694340 | ||
| Pubmed | Four DAZ genes in two clusters found in the AZFc region of the human Y chromosome. | 6.36e-14 | 4 | 19 | 4 | 10936047 | |
| Pubmed | [Study on DAZ gene copy deletion in severe oligozoospermia sperm donor for ICSI]. | 6.36e-14 | 4 | 19 | 4 | 16963411 | |
| Pubmed | 6.36e-14 | 4 | 19 | 4 | 9321470 | ||
| Pubmed | 6.36e-14 | 4 | 19 | 4 | 19223287 | ||
| Pubmed | Partial DAZ deletions in a family with five infertile brothers. | 6.36e-14 | 4 | 19 | 4 | 12801575 | |
| Pubmed | In vivo and in vitro analysis of homodimerisation activity of the mouse Dazl1 protein. | 3.18e-13 | 5 | 19 | 4 | 10903443 | |
| Pubmed | 3.18e-13 | 5 | 19 | 4 | 23298641 | ||
| Pubmed | 3.18e-13 | 5 | 19 | 4 | 23579190 | ||
| Pubmed | Germline DNA demethylation dynamics and imprint erasure through 5-hydroxymethylcytosine. | 3.18e-13 | 5 | 19 | 4 | 23223451 | |
| Pubmed | 3.18e-13 | 5 | 19 | 4 | 34985827 | ||
| Pubmed | 3.18e-13 | 5 | 19 | 4 | 11804965 | ||
| Pubmed | 3.18e-13 | 5 | 19 | 4 | 9143498 | ||
| Pubmed | Expression profiling of the developing testis in wild-type and Dazl knockout mice. | 3.18e-13 | 5 | 19 | 4 | 14648873 | |
| Pubmed | DAZL is essential for stress granule formation implicated in germ cell survival upon heat stress. | 3.18e-13 | 5 | 19 | 4 | 22223682 | |
| Pubmed | Bisphenol A exposure modifies DNA methylation of imprint genes in mouse fetal germ cells. | 3.18e-13 | 5 | 19 | 4 | 22699882 | |
| Pubmed | A murine homologue of the human DAZ gene is autosomal and expressed only in male and female gonads. | 3.18e-13 | 5 | 19 | 4 | 8845845 | |
| Pubmed | 3.18e-13 | 5 | 19 | 4 | 8896558 | ||
| Pubmed | 3.18e-13 | 5 | 19 | 4 | 11058556 | ||
| Pubmed | AZFc partial deletions in Chilean men with severe spermatogenic failure. | 3.18e-13 | 5 | 19 | 4 | 17416365 | |
| Pubmed | Dazl promotes germ cell differentiation from embryonic stem cells. | 3.18e-13 | 5 | 19 | 4 | 19783541 | |
| Pubmed | Kinked β-strands mediate high-affinity recognition of mRNA targets by the germ-cell regulator DAZL. | 3.18e-13 | 5 | 19 | 4 | 22021443 | |
| Pubmed | 3.18e-13 | 5 | 19 | 4 | 22293198 | ||
| Pubmed | The mouse Dazla gene encodes a cytoplasmic protein essential for gametogenesis. | 3.18e-13 | 5 | 19 | 4 | 9288969 | |
| Pubmed | 3.18e-13 | 5 | 19 | 4 | 20008336 | ||
| Pubmed | 3.18e-13 | 5 | 19 | 4 | 23456578 | ||
| Pubmed | 3.18e-13 | 5 | 19 | 4 | 17761180 | ||
| Pubmed | Isolation of a mouse homolog of the human DAZ (Deleted in Azoospermia) gene. | 3.18e-13 | 5 | 19 | 4 | 8679003 | |
| Pubmed | A human DAZ transgene confers partial rescue of the mouse Dazl null phenotype. | 3.18e-13 | 5 | 19 | 4 | 10393944 | |
| Pubmed | The human autosomal gene DAZLA: testis specificity and a candidate for male infertility. | 3.18e-13 | 5 | 19 | 4 | 8968756 | |
| Pubmed | 3.18e-13 | 5 | 19 | 4 | 8968755 | ||
| Pubmed | DAZL Regulates Germ Cell Survival through a Network of PolyA-Proximal mRNA Interactions. | 3.18e-13 | 5 | 19 | 4 | 30380414 | |
| Pubmed | 3.18e-13 | 5 | 19 | 4 | 19468308 | ||
| Pubmed | Regulated Formation of an Amyloid-like Translational Repressor Governs Gametogenesis. | 3.18e-13 | 5 | 19 | 4 | 26411291 | |
| Pubmed | 3.18e-13 | 5 | 19 | 4 | 9700189 | ||
| Pubmed | Partial rescue of the Dazl knockout mouse by the human DAZL gene. | 3.18e-13 | 5 | 19 | 4 | 12200456 | |
| Pubmed | 3.18e-13 | 5 | 19 | 4 | 11514340 | ||
| Pubmed | 3.18e-13 | 5 | 19 | 4 | 21270429 | ||
| Pubmed | 3.18e-13 | 5 | 19 | 4 | 11089564 | ||
| Pubmed | 3.18e-13 | 5 | 19 | 4 | 8661148 | ||
| Pubmed | 9.53e-13 | 6 | 19 | 4 | 32170089 | ||
| Pubmed | Genetic mapping of a male germ cell-expressed gene Tpx-2 to mouse chromosome 17. | 9.53e-13 | 6 | 19 | 4 | 1869307 | |
| Pubmed | 9.53e-13 | 6 | 19 | 4 | 16278232 | ||
| Pubmed | 9.53e-13 | 6 | 19 | 4 | 1638086 | ||
| Pubmed | 9.53e-13 | 6 | 19 | 4 | 20157580 | ||
| Pubmed | DAZL binds to the transcripts of several Tssk genes in germ cells. | 9.53e-13 | 6 | 19 | 4 | 18452650 | |
| Pubmed | Spermatogenesis in testes of Dazl null mice after transplantation of wild-type germ cells. | 9.53e-13 | 6 | 19 | 4 | 14611632 | |
| Pubmed | DAZL binds to 3'UTR of Tex19.1 mRNAs and regulates Tex19.1 expression. | 9.53e-13 | 6 | 19 | 4 | 19247806 | |
| Pubmed | 9.53e-13 | 6 | 19 | 4 | 17219433 | ||
| Pubmed | The fate of granulosa cells following premature oocyte loss and the development of ovarian cancers. | 9.53e-13 | 6 | 19 | 4 | 23417416 | |
| Pubmed | 9.53e-13 | 6 | 19 | 4 | 28496037 | ||
| Pubmed | DAZL regulates Tet1 translation in murine embryonic stem cells. | 9.53e-13 | 6 | 19 | 4 | 26077710 | |
| Pubmed | 9.53e-13 | 6 | 19 | 4 | 32962040 | ||
| Pubmed | 9.53e-13 | 6 | 19 | 4 | 17526644 | ||
| Pubmed | 2.22e-12 | 7 | 19 | 4 | 11410654 | ||
| Pubmed | DAZL and CPEB1 regulate mRNA translation synergistically during oocyte maturation. | 2.22e-12 | 7 | 19 | 4 | 26826184 | |
| Pubmed | 2.22e-12 | 7 | 19 | 4 | 15081113 | ||
| Pubmed | 2.22e-12 | 7 | 19 | 4 | 22699423 | ||
| Pubmed | 2.22e-12 | 7 | 19 | 4 | 11604102 | ||
| Pubmed | Dazl can bind to dynein motor complex and may play a role in transport of specific mRNAs. | 2.22e-12 | 7 | 19 | 4 | 16946704 | |
| Pubmed | 2.22e-12 | 7 | 19 | 4 | 10857750 | ||
| Pubmed | The Dazh gene is expressed in male and female embryonic gonads before germ cell sex differentiation. | 2.22e-12 | 7 | 19 | 4 | 9588208 | |
| Pubmed | 4.45e-12 | 8 | 19 | 4 | 10951504 | ||
| Pubmed | 4.45e-12 | 8 | 19 | 4 | 33749946 | ||
| Pubmed | Hypomethylating therapy in an aggressive stroma-rich model of pancreatic carcinoma. | 4.45e-12 | 8 | 19 | 4 | 23204224 | |
| Pubmed | 4.45e-12 | 8 | 19 | 4 | 10823932 | ||
| Pubmed | 4.45e-12 | 8 | 19 | 4 | 29883445 | ||
| Pubmed | 4.45e-12 | 8 | 19 | 4 | 22621333 | ||
| Pubmed | 4.45e-12 | 8 | 19 | 4 | 32686646 | ||
| Pubmed | Mouse dead end1 acts with Nanos2 and Nanos3 to regulate testicular teratoma incidence. | 4.45e-12 | 8 | 19 | 4 | 32339196 | |
| Pubmed | 4.45e-12 | 8 | 19 | 4 | 11869379 | ||
| Pubmed | A Gene Regulatory Program for Meiotic Prophase in the Fetal Ovary. | 8.00e-12 | 9 | 19 | 4 | 26378784 | |
| Pubmed | Embryoid bodies from mouse stem cells express oxytocin receptor, Oct-4 and DAZL. | 8.00e-12 | 9 | 19 | 4 | 19695304 | |
| Pubmed | Dazl deficiency leads to embryonic arrest of germ cell development in XY C57BL/6 mice. | 8.00e-12 | 9 | 19 | 4 | 16310179 | |
| Pubmed | 8.00e-12 | 9 | 19 | 4 | 28235998 | ||
| Pubmed | 8.00e-12 | 9 | 19 | 4 | 20159962 | ||
| Pubmed | 1.33e-11 | 10 | 19 | 4 | 31234534 | ||
| Pubmed | Tesmin transcription is regulated differently during male and female meiosis. | 1.33e-11 | 10 | 19 | 4 | 14648882 | |
| Pubmed | MAX controls meiotic entry in sexually undifferentiated germ cells. | 1.33e-11 | 10 | 19 | 4 | 38433229 | |
| Pubmed | 1.33e-11 | 10 | 19 | 4 | 9922113 | ||
| Pubmed | 1.33e-11 | 10 | 19 | 4 | 23810942 | ||
| Pubmed | 1.33e-11 | 10 | 19 | 4 | 12837688 | ||
| Pubmed | 1.33e-11 | 10 | 19 | 4 | 10601091 | ||
| Pubmed | NANOS2 suppresses the cell cycle by repressing mTORC1 activators in embryonic male germ cells. | 2.09e-11 | 11 | 19 | 4 | 34401671 | |
| Pubmed | Deterministic and stochastic allele specific gene expression in single mouse blastomeres. | 3.07e-11 | 424 | 19 | 8 | 21731673 | |
| Pubmed | Retinoic acid activates two pathways required for meiosis in mice. | 3.14e-11 | 12 | 19 | 4 | 25102060 | |
| Interaction | BOLL interactions | 7.97e-06 | 42 | 19 | 3 | int:BOLL | |
| Interaction | DAZ4 interactions | 1.76e-05 | 7 | 19 | 2 | int:DAZ4 | |
| Interaction | DAZ1 interactions | 4.61e-05 | 11 | 19 | 2 | int:DAZ1 | |
| Interaction | GTF2IRD2 interactions | 5.53e-05 | 12 | 19 | 2 | int:GTF2IRD2 | |
| Interaction | GTF2IRD2B interactions | 8.78e-05 | 15 | 19 | 2 | int:GTF2IRD2B | |
| Cytoband | Yq11.223 | 5.97e-08 | 93 | 19 | 4 | Yq11.223 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrYq11 | 7.39e-06 | 311 | 19 | 4 | chrYq11 | |
| Cytoband | 7q11.23 | 7.38e-04 | 97 | 19 | 2 | 7q11.23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q11 | 5.56e-03 | 271 | 19 | 2 | chr7q11 | |
| GeneFamily | RNA binding motif containing | 1.19e-06 | 213 | 17 | 5 | 725 | |
| GeneFamily | Zinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases | 9.91e-05 | 16 | 17 | 2 | 66 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 1.12e-04 | 17 | 17 | 2 | 486 | |
| GeneFamily | PHD finger proteins | 3.17e-03 | 90 | 17 | 2 | 88 | |
| Coexpression | TESAR_JAK_TARGETS_MOUSE_ES_D3_DN | 9.72e-11 | 12 | 19 | 4 | MM742 | |
| Coexpression | SASAI_TARGETS_OF_CXCR6_AND_PTCH1_DN | 9.72e-11 | 12 | 19 | 4 | MM781 | |
| Coexpression | WAGSCHAL_EHMT2_TARGETS_UP | 1.73e-09 | 23 | 19 | 4 | MM1293 | |
| Coexpression | MATZUK_SPERMATOGONIA | 6.13e-09 | 31 | 19 | 4 | MM765 | |
| Coexpression | CHEN_ETV5_TARGETS_TESTIS | 7.96e-09 | 33 | 19 | 4 | MM701 | |
| Coexpression | MADAN_DPPA4_TARGETS | 4.03e-07 | 86 | 19 | 4 | MM1312 | |
| Coexpression | JACKSON_DNMT1_TARGETS_UP | 5.53e-07 | 93 | 19 | 4 | MM1185 | |
| Coexpression | GSE4590_PRE_BCELL_VS_LARGE_PRE_BCELL_DN | 1.87e-04 | 156 | 19 | 3 | M6865 | |
| Coexpression | WANG_RESPONSE_TO_BEXAROTENE_DN | 2.14e-04 | 30 | 19 | 2 | MM532 | |
| Coexpression | WANG_RESPONSE_TO_BEXAROTENE_DN | 2.14e-04 | 30 | 19 | 2 | M1264 | |
| Coexpression | MCCABE_BOUND_BY_HOXC6 | 2.97e-04 | 461 | 19 | 4 | M6376 | |
| Coexpression | FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_18HR_TO_48HR_EARLY_DN | 3.45e-04 | 38 | 19 | 2 | M40960 | |
| Coexpression | GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH2_UP | 3.82e-04 | 199 | 19 | 3 | M4526 | |
| Coexpression | GSE33162_HDAC3_KO_VS_HDAC3_KO_4H_LPS_STIM_MACROPHAGE_UP | 3.88e-04 | 200 | 19 | 3 | M9041 | |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED | 6.79e-04 | 574 | 19 | 4 | MM820 | |
| Drug | boron trichloride | 5.19e-12 | 6 | 19 | 4 | CID000025135 | |
| Drug | Vistar | 8.47e-11 | 36 | 19 | 5 | CID000040896 | |
| Drug | molybdenum disulfide | 2.15e-10 | 43 | 19 | 5 | CID000014823 | |
| Drug | desmethylazelastine | 6.26e-10 | 16 | 19 | 4 | CID000162558 | |
| Drug | dazmegrel | 1.33e-09 | 19 | 19 | 4 | CID000053555 | |
| Drug | YM 026 | 1.33e-09 | 19 | 19 | 4 | CID000004443 | |
| Drug | dansylaziridine | 3.04e-09 | 23 | 19 | 4 | CID000104008 | |
| Drug | AZFd | 3.04e-09 | 23 | 19 | 4 | CID000196489 | |
| Drug | d-gluconhydroximo-1,5-lactam | 1.07e-08 | 31 | 19 | 4 | CID000003479 | |
| Drug | 3-bromo-7-nitroindazole | 2.01e-08 | 36 | 19 | 4 | CID000001649 | |
| Drug | 2-chlorodideoxyadenosine | 4.19e-08 | 43 | 19 | 4 | CID000072194 | |
| Drug | propham | 4.60e-08 | 44 | 19 | 4 | CID000024685 | |
| Drug | ridogrel | 9.14e-08 | 52 | 19 | 4 | CID005362391 | |
| Drug | azafagomine | 1.33e-07 | 57 | 19 | 4 | CID011957435 | |
| Drug | NSC56408 | 1.87e-07 | 62 | 19 | 4 | CID000005604 | |
| Drug | kt S | 2.42e-07 | 66 | 19 | 4 | CID006399216 | |
| Drug | azelastine | 3.84e-07 | 74 | 19 | 4 | CID000002267 | |
| Drug | p11-13 | 4.05e-07 | 75 | 19 | 4 | CID000015759 | |
| Drug | BW755C | 9.65e-07 | 93 | 19 | 4 | CID000047795 | |
| Drug | bipy | 1.14e-06 | 97 | 19 | 4 | CID000001474 | |
| Drug | carbonyl sulfide | 2.34e-06 | 116 | 19 | 4 | CID000010039 | |
| Drug | TXB2 (thromboxane B2 | 2.50e-06 | 118 | 19 | 4 | CID000005461 | |
| Drug | benzoyl-S-CoA | 1.48e-05 | 58 | 19 | 3 | CID000122174 | |
| Drug | AC1LCVO8 | 1.84e-05 | 8 | 19 | 2 | CID000656891 | |
| Drug | thromboxane | 3.09e-05 | 223 | 19 | 4 | CID000114873 | |
| Drug | C04424 | 3.61e-05 | 11 | 19 | 2 | CID011953835 | |
| Drug | C05118 | 4.33e-05 | 12 | 19 | 2 | CID000440565 | |
| Drug | C05119 | 4.33e-05 | 12 | 19 | 2 | CID000440566 | |
| Drug | AC1L9EUB | 5.12e-05 | 13 | 19 | 2 | CID000443527 | |
| Drug | AC1LCVO5 | 5.97e-05 | 14 | 19 | 2 | CID000656890 | |
| Drug | AC1L9EU8 | 5.97e-05 | 14 | 19 | 2 | CID000443526 | |
| Drug | TiNi | 7.57e-05 | 100 | 19 | 3 | CID000159408 | |
| Drug | neocarzinostatin chromophore | 8.37e-05 | 288 | 19 | 4 | CID000447545 | |
| Drug | AC1L9ASI | 8.91e-05 | 17 | 19 | 2 | CID000441230 | |
| Drug | N-methyl-1(R)-aminoindan | 1.72e-04 | 132 | 19 | 3 | CID005494442 | |
| Drug | pristane | 2.61e-04 | 152 | 19 | 3 | CID000015979 | |
| Drug | anacardic acid | 2.83e-04 | 30 | 19 | 2 | CID000167551 | |
| Drug | 2-methylbutyryl-CoA | 4.32e-04 | 37 | 19 | 2 | CID000000054 | |
| Drug | 1ec0 | 4.56e-04 | 38 | 19 | 2 | CID000445306 | |
| Drug | 2-propylpentanoic acid; Down 200; 1000uM; PC3; HG-U133A | 5.34e-04 | 194 | 19 | 3 | 433_DN | |
| Drug | AC1L1G5B | 6.68e-04 | 46 | 19 | 2 | CID000003531 | |
| Drug | gamma-cyhalothrin | 6.97e-04 | 47 | 19 | 2 | CID000443046 | |
| Drug | isovaleryl-CoA | 8.86e-04 | 53 | 19 | 2 | CID000000810 | |
| Drug | 3-Hydroxybutanoyl-Coenzyme A | 1.02e-03 | 57 | 19 | 2 | CID000000521 | |
| Drug | Probenecid | 1.10e-03 | 59 | 19 | 2 | ctd:D011339 | |
| Drug | NSC9700 | 1.18e-03 | 578 | 19 | 4 | CID000005408 | |
| Disease | Male sterility due to Y-chromosome deletions | 8.58e-12 | 8 | 19 | 4 | C2931163 | |
| Disease | Partial chromosome Y deletion | 8.58e-12 | 8 | 19 | 4 | C1507149 | |
| Disease | Spermatogenic Failure, Nonobstructive, Y-Linked | 1.26e-07 | 16 | 19 | 3 | C1839071 | |
| Disease | Spermatogenic failure, Y-linked, 2 | 1.26e-07 | 16 | 19 | 3 | cv:C1839071 | |
| Disease | SPERMATOGENIC FAILURE, Y-LINKED, 2 | 1.26e-07 | 16 | 19 | 3 | 415000 | |
| Disease | Medulloblastoma | 4.72e-04 | 50 | 19 | 2 | C0025149 | |
| Disease | urinary bladder cancer (is_implicated_in) | 1.09e-03 | 76 | 19 | 2 | DOID:11054 (is_implicated_in) | |
| Disease | circadian rhythm | 4.88e-03 | 163 | 19 | 2 | EFO_0004354 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VAQPIYQQPAYHYQA | 171 | Q8N9W6 | |
| TGYQFHVYNYQMPPQ | 516 | Q13117 | |
| QVTTGYQFHVYNYQM | 441 | Q9NR90 | |
| YQFHVYNYQMPPQCP | 446 | Q9NR90 | |
| YHSNHGYMNQTPQYP | 2006 | Q8WYB5 | |
| MHYDQSQPPYYNVTA | 316 | P07098 | |
| YHSNPAYMNQTAQYP | 1936 | Q92794 | |
| IGYNYTYMPNQFNHD | 46 | Q9H461 | |
| TTGYQFHVYNYQMPP | 701 | Q9NQZ3 | |
| FMQPVYNPHQQYSVY | 306 | Q71RC2 | |
| YNPHQQYSVYSIVPQ | 311 | Q71RC2 | |
| TTGYQFHVYNYQMPP | 536 | Q86SG3 | |
| PNYYQYNMQGSHPSS | 241 | Q86UP8 | |
| PNYYQYNMQGSHPSS | 241 | Q6EKJ0 | |
| PTSLHYMNPYQLNAY | 326 | Q86YQ8 | |
| FAYYQEYPMSIQQAQ | 316 | Q9Y289 | |
| PQAVYYFHPQYLVNV | 271 | O15466 | |
| YTQPHPNTVYQYGDM | 26 | Q9NZ72 | |
| MQQPFNYPYPQIYWV | 1 | P48023 | |
| VNEVYHMYNRHQYPF | 306 | P54278 | |
| PHPYSKMYILVQYNN | 316 | Q5R3F8 |